These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 1355660)

  • 1. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
    Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
    Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
    Gekeler V; Beck J; Noller A; Wilisch A; Frese G; Neumann M; Handgretinger R; Ehninger G; Probst H; Niethammer D
    Ann Hematol; 1994; 69 Suppl 1():S19-24. PubMed ID: 7914748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias.
    Beck J; Niethammer D; Gekeler V
    Cancer Lett; 1994 Oct; 86(1):135-42. PubMed ID: 7954350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of DNA topoisomerase I and II gene and the genes possibly related to drug resistance in human myeloma cells.
    Ishikawa H; Kawano MM; Okada K; Tanaka H; Tanabe O; Sakai A; Asaoku H; Iwato K; Nobuyoshi M; Kuramoto A
    Br J Haematol; 1993 Jan; 83(1):68-74. PubMed ID: 8094626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.
    Beck J; Handgretinger R; Dopfer R; Klingebiel T; Niethammer D; Gekeler V
    Br J Haematol; 1995 Feb; 89(2):356-63. PubMed ID: 7873386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML.
    Beck J; Handgretinger R; Klingebiel T; Dopfer R; Schaich M; Ehninger G; Niethammer D; Gekeler V
    Leukemia; 1996 Mar; 10(3):426-33. PubMed ID: 8642857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
    Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
    Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias.
    Russo D; Marie JP; Zhou DC; Faussat AM; Delmer A; Maisonneuve L; Ngoc LH; Baccarani M; Zittoun R
    Leukemia; 1994 May; 8(5):881-4. PubMed ID: 7910222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias.
    Beck J; Niethammer D; Gekeler V
    Leukemia; 1996 Jul; 10 Suppl 3():S39-S45. PubMed ID: 8656699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
    Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
    Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ; Kakehi Y; Yoshida O
    Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of resistance genes in acute leukemia.
    Zhou DC; Hoang-Ngoc L; Delmer A; Faussat AM; Russo D; Zittoun R; Marie JP
    Leuk Lymphoma; 1994; 13 Suppl 1():27-30. PubMed ID: 8075575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage.
    Ito Y; Tanimoto M; Kumazawa T; Okumura M; Morishima Y; Ohno R; Saito H
    Cancer; 1989 Apr; 63(8):1534-8. PubMed ID: 2564311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
    Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
    Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia.
    Albertioni F; Gruber A; Areström I; Vitols S
    Med Oncol; 1995 Jun; 12(2):79-86. PubMed ID: 8535665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors contributing to adriamycin sensitivity in human xenograft tumors: the relationship between expression of the MDR1, GST-pi and topoisomerase II genes and tumor sensitivity to adriamycin.
    Kim R; Hirabayashi N; Nishiyama M; Jinushi K; Toge T; Okada K
    Anticancer Res; 1992; 12(1):241-5. PubMed ID: 1314532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression.
    Norris MD; Haber M; King M; Davey RA
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1435-41. PubMed ID: 2575383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity.
    Keith WN; Stallard S; Brown R
    Br J Cancer; 1990 May; 61(5):712-6. PubMed ID: 1970934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.